Neuburgh Advisers’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$30K Hold
1,904
﹤0.01% 863
2019
Q2
$39K Hold
1,904
﹤0.01% 869
2019
Q1
$33K Hold
1,904
﹤0.01% 868
2018
Q4
$24K Buy
+1,904
New +$24K ﹤0.01% 856